Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for reduction of post-anesthesia hepatitis risk
IRCT2014091919199N2Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of acetylcysteine in Drug-induced hepatitis (DILI) and chemical and drug induced liver injury (DILI), sponsored by Arak University of Medical Sciences. Started Apr 2014; status: completed.
02
Drugs
acetylcysteine
03
Conditions
Drug-induced hepatitis (DILI)chemical and drug induced liver injury (DILI)
Beyond the preview
Go deeper on IRCT2014091919199N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014091919199N2.